Product Information
MY WAY 1.5 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $6.3305 per EA under NDC 68180085211. Its NADAC has been published 490 times since May 17, 2017.
FDA first approved this application on Jun 19, 2014.
The High Outlier badge above means this manufacturer's average price in the levonorgestrel market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1.5 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180085211
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LEVONORGESTRELApproval Type
Generic (ANDA)
FDA Application
ANDA201446FDA Approved
6/19/2014
On Market Since
4/25/2017
Pharmacological Classes
Price Statistics
The NADAC for MY WAY 1.5 MG TABLET has been published 490 times since May 17, 2017, and over the history we have for it it has declined 69.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.3305 per EA |
|---|---|
| All-time high | $20.9571 (Nov 15, 2017) |
| All-time low | $5.2568 (Nov 20, 2024) |
| 52-week high | $6.8109 |
| 52-week low | $6.2162 |
| Median price | $9.2787 |
| Average price | $9.9850 |
| Largest weekly change | +32.8% (Jun 20, 2018) |
| Weeks tracked | 490 |
| Tracking since | May 17, 2017 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
levonorgestrel market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Progestin class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MY WAY 1.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MY WAY 1.5 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $6.3305 per EA (NDC 68180085211), effective Sep 30, 2026.
How has the price of MY WAY 1.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MY WAY 1.5 MG TABLET has declined 69.8%. It has been tracked across 490 weekly CMS publications since May 17, 2017.
What are the highest and lowest recorded NADAC prices for MY WAY 1.5 MG TABLET?
Since May 17, 2017, the NADAC for MY WAY 1.5 MG TABLET has ranged from a low of $5.2568 (Nov 20, 2024) to a high of $20.9571 (Nov 15, 2017), with a median of $9.2787 per EA.
Are there cheaper alternatives to MY WAY 1.5 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MY WAY 1.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MY WAY 1.5 MG TABLET?
MY WAY 1.5 MG TABLET (NDC 68180085211) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.